Upper limb (UL) function impairment is prevalent among patients with primary progressive multiple sclerosis (PPMS) and alters a patient’s quality of life. Researchers set out to evaluate the effect of Ocrelizumab on upper limb function using the nine-hole peg test (9HPT)...Read more - http://www.ms-uk.org/ocrelizumab-lowers ... ts-ectrims
